Board of Visitors
Joseph T. Abdalla '89, MBA
General Manager
Commercial StrategyGroup
United BioSource Corporation
George Abercrombie '78, MBA
Paul J. Atkins, PhD
Chief Executive Officer
Oriel Therapeutics
James W. Crow
United Therapeutics, Inc.
Founder, President, and Chief Operating Officer (Retired)
Marty DeBerardinis, PhD ‘82
Director, Medicines Evaluation–Infection US/UK
R&D Pharmaceutical Development
AstraZeneca Pharmaceuticals LP
Fred Eshelman '72, PharmD
Executive Chairman
Pharmaceutical Product Development
Neal Fowler '84, MBA '88
CEO
Liquidia Technologies
Joe Graedon, MS
President
Graedon Enterprises, Inc.
The People’s Pharmacy
Mark Gregory
Vice President of Pharmacy and Government Relations
Kerr Drug, Inc.
Reg Hardy ’81, MBA
Jimmy Jackson
Spoke Consulting, Inc.
M. Ross Johnson, PhD
President and CEO
Parion Sciences, Inc.
Bryant Mangum '74
Vice President Pharmacy Services
Premier, Inc.
Bruce McWhinney, PharmD
Bernard Consulting Group
Douglas W. Mendenhall, PhD
dwm Consulting, LLC
David S. Moody '73
CEO
Mutual Drug Company
William “Whit” Moose '60
Past President, NCPA
Moose Drug Company
Louis A. Newsome '77
UnitedHealthcare of North Carolina
Pharmacy Account Executive, Mid-Atlantic Region
Frank Press
Huron Consulting Group
Ron H. Small '66, MBA
Vice President, Quality Outcomes
Interim VP/CIO Informatics
Chief Pharmacy Officer
NC Baptist Hospital
Wake Forest University Baptist Medical Center
Catherine C. Stokes, MS '86
President and CEO
Drug Safety Alliance, Inc.
Chris L. Waller, PhD '92
Senior Director, HealthCare Informatics
Medical Business Technology
Pfizer
